Cost-effectiveness of rotavirus vaccination in Mozambique

Funding Information: The authors received funding from Bill and Melinda Gates Foundation (OPP1147721), through PATH subaward number: GAT.2111-01707508-SUB. Funding Information: We thank the EPI and the NITAG, from Mozambique for their support and commitment to the present analysis. We also thank PAT...

ver descrição completa

Detalhes bibliográficos
Autor principal: Lourenço Guimarães, Esperança (author)
Outros Autores: Chissaque, Assucênio (author), Pecenka, Clint (author), Clark, Andrew (author), Vaz, Basília (author), Banze, Arlindo (author), Canana, Neide (author), Romão, Clésio (author), do Rosário Oliveira Martins, Maria (author), de Deus, Nilsa (author), Debellut, Frédéric (author)
Formato: article
Idioma:eng
Publicado em: 2022
Assuntos:
Cost-effectiveness
Diarrhea
Modelling
Mozambique
Rotavirus
UNIVAC
Vaccination
Molecular Medicine
Immunology and Microbiology(all)
veterinary(all)
Public Health, Environmental and Occupational Health
Infectious Diseases
SDG 3 - Good Health and Well-being
Texto completo:http://hdl.handle.net/10362/145718
País:Portugal
Oai:oai:run.unl.pt:10362/145718

Texto Completo

http://hdl.handle.net/10362/145718

Registos relacionados